| Nov 4 |
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
|
| Nov 4 |
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic
|
| Nov 1 |
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate
|
| Oct 31 |
Cormedix Inc (CRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses
|
| Oct 30 |
CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript
|
| Oct 30 |
CorMedix GAAP EPS of -$0.05 beats by $0.05, revenue of $11.46M beats by $0.62M
|
| Oct 30 |
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update
|
| Oct 29 |
CorMedix Q3 2024 Earnings Preview
|
| Oct 28 |
CorMedix 2.0: New Leadership, New Approval, New Focus
|
| Oct 24 |
CorMedix Inc. Announces New Data at ASN Kidney Week 2024
|
